Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Tomek Allison F
2. Date of Event Requiring Statement (Month/Day/Year)
3. Issuer Name and Ticker or Trading Symbol
C-Bond Systems, Inc [CBNT]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 5,050,000 (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Convertible Preferred Stock   (3)   (4) Common Stock 10,361,303 (2) $ (2) D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Tomek Allison F


/s/ Allison Tomek 03/19/2021
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) C-Bond Systems, Inc. (the "Company") granted to Ms. Tomek 250,000 restricted shares of common stock, par value $0.001 ("Common Stock"), on October 6, 2018; 1,500,000 restricted shares of Common Stock on July 29, 2019; and 1,000,000 restricted shares of Common Stock on April 28, 2020 as incentive compensation during the years of 2018 through 2020. The 2,750,000 shares are fully vested. The Company issued 2,000,000 restricted shares of Common Stock on March 8, 2021, as incentive compensation for her new role as President and a member of the Company's Board of Directors. The 2,000,000 shares of restricted stock vest on May 1, 2022. On July 12, 2019, Ms. Tomek elected to convert $12,000 of deferred compensation owed to her into 300,000 restricted shares of Common Stock. The 300,000 shares of restricted stock vest on May 1, 2021. The aforementioned vesting dates may be extended by mutual consent of the Board of Directors and Ms. Tomek.
(2) On December 21, 2020 and January 18, 2021, pursuant to a liability reduction plan, C-Bond Systems, Inc. issued Ms. Tomek 45 shares and 20 shares, respectively, of the Company's Series B Convertible Preferred Stock ("Series B"). The 45 shares and 20 shares of Series B have a stated value of $1,000 per share and are convertible into shares of Common Stock at $0.027 per share and $0.08 per share, respectively, the low trading prices of the Common Stock on the dates of issuance, which prices are subject to adjustment as described in the Company's Certificate of Designations of Preferences, Rights and Limitations of Series B Preferred Stock.
(3) The shares of Series B granted to Ms. Tomek vest on May 1, 2021, subject to extension as mutually agreed upon by the Board and Ms. Tomek.
(4) No expiration date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.